Skip to content
Disclosery

EXANE DERIVATIVES: LULU position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on LULU, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 114 LULU shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 114 shares
    Change vs previous 13F -270 shares

    0.02% of the 13F portfolio, value $31,073.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 384 shares
    Change vs previous 13F +55 shares

    0.04% of the 13F portfolio, value $140,245.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 329 shares
    Change vs previous 13F -115 shares

    0.03% of the 13F portfolio, value $128,787.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 444 shares
    Change vs previous 13F -74 shares

    0.04% of the 13F portfolio, value $179,687.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 518 shares
    Change vs previous 13F -162 shares

    0.05% of the 13F portfolio, value $192,059.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 680 shares
    Change vs previous 13F -267 shares

    0.06% of the 13F portfolio, value $208,563.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 947 shares
    Change vs previous 13F +943 shares

    0.1% of the 13F portfolio, value $329,584.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 4 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,317.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).